297 related articles for article (PubMed ID: 27453280)
1. Knockdown of eIF3a ameliorates cardiac fibrosis by inhibiting the TGF-β1/Smad3 signaling pathway.
Li B; Chen H; Yang X; Wang Y; Qin L; Chu Y
Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):97-101. PubMed ID: 27453280
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of eIF3a attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.
He P; Yu ZJ; Sun CY; Jiao SJ; Jiang HQ
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):107-11. PubMed ID: 27262813
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of elF3a inhibits collagen synthesis in renal fibroblasts via Inhibition of transforming growth factor-β1/Smad signaling pathway.
Zhang YF; Wang Q; Luo J; Yang S; Wang JL; Li HY
Int J Clin Exp Pathol; 2015; 8(8):8983-9. PubMed ID: 26464640
[TBL] [Abstract][Full Text] [Related]
4. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
5. NLRC5 silencing ameliorates cardiac fibrosis by inhibiting the TGF‑β1/Smad3 signaling pathway.
Zhou H; Yu X; Zhou G
Mol Med Rep; 2017 Sep; 16(3):3551-3556. PubMed ID: 28713900
[TBL] [Abstract][Full Text] [Related]
6. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
7. Role of eukaryotic translation initiation factor 3a in bleomycin-induced pulmonary fibrosis.
Li XW; Wu YH; Li XH; Li D; Du J; Hu CP; Li YJ
Eur J Pharmacol; 2015 Feb; 749():89-97. PubMed ID: 25592322
[TBL] [Abstract][Full Text] [Related]
8. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
9. Role of eukaryotic translation initiation factors 3a in hypoxia-induced right ventricular remodeling of rats.
Li WQ; Li XH; Wu YH; Du J; Wang AP; Li D; Li YJ
Life Sci; 2016 Jan; 144():61-8. PubMed ID: 26612348
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of l-mimosine on bleomycin-induced pulmonary fibrosis in rats: Role of eIF3a and p27.
Li XW; Hu CP; Li YJ; Gao YX; Wang XM; Yang JR
Int Immunopharmacol; 2015 Jul; 27(1):53-64. PubMed ID: 25957199
[TBL] [Abstract][Full Text] [Related]
11. FOXF1 ameliorates angiotensin II-induced cardiac fibrosis in cardiac fibroblasts through inhibiting the TGF-β1/Smad3 signaling pathway.
Jin D; Han F
J Recept Signal Transduct Res; 2020 Dec; 40(6):493-500. PubMed ID: 32496870
[TBL] [Abstract][Full Text] [Related]
12. Fluorofenidone attenuates bleomycin-induced pulmonary fibrosis by inhibiting eukaryotic translation initiation factor 3a (eIF3a) in rats.
Wu YH; Li XW; Li WQ; Li XH; Li YJ; Hu GY; Liu ZQ; Li D
Eur J Pharmacol; 2016 Feb; 773():42-50. PubMed ID: 26821114
[TBL] [Abstract][Full Text] [Related]
13. Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1.
Ma J; Ma SY; Ding CH
Chin J Integr Med; 2017 May; 23(5):362-369. PubMed ID: 26956464
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of elF3a inhibits TGF‑β1‑induced extracellular matrix protein expression in keloid fibroblasts.
Li T; Zhao J
Mol Med Rep; 2018 Mar; 17(3):4057-4061. PubMed ID: 29286129
[TBL] [Abstract][Full Text] [Related]
15. [Effects of calcitonin gene-related peptide on eIF3a and p27 expression in bleomycin-induced pulmonary fibrosis of rats].
Li XW; Zuo DZ; Shen YY; Hao W
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Jan; 33(1):16-21. PubMed ID: 29926601
[TBL] [Abstract][Full Text] [Related]
16. C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation.
Lei H; Wu D; Wang JY; Li L; Zhang CL; Feng H; Fu FY; Wu LL
Basic Res Cardiol; 2015; 110(4):35. PubMed ID: 25962701
[TBL] [Abstract][Full Text] [Related]
17. Rutaecarpine attenuates hypoxia-induced right ventricular remodeling in rats.
Li WQ; Li XH; Du J; Zhang W; Li D; Xiong XM; Li YJ
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):757-67. PubMed ID: 27052575
[TBL] [Abstract][Full Text] [Related]
18. Notch signaling inhibits cardiac fibroblast to myofibroblast transformation by antagonizing TGF-β1/Smad3 signaling.
Zhou XL; Fang YH; Wan L; Xu QR; Huang H; Zhu RR; Wu QC; Liu JC
J Cell Physiol; 2019 Jun; 234(6):8834-8845. PubMed ID: 30317638
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation regulates α-smooth muscle actin expression during cardiac fibroblast differentiation.
He Y; Ling S; Sun Y; Sheng Z; Chen Z; Pan X; Ma G
J Cell Physiol; 2019 May; 234(5):7174-7185. PubMed ID: 30362530
[TBL] [Abstract][Full Text] [Related]
20. DIM attenuates TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts.
Li J; Zhang W; Jiao R; Yang Z; Yuan Y; Wu Q; Hu Z; Xiang S; Tang Q
Int J Clin Exp Pathol; 2015; 8(5):5121-8. PubMed ID: 26191207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]